Shareholding disclosure

Novartis AG

Declared position

5.002%

Threshold

Crossed upwards

Timeline

Published

01.07.2022

Transaction

28.06.2022

Voting rights breakdown

Voting rights acquired5.002%

Voting rights sold0.983%

Below threshold0%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TAM6U00029

Beneficial owner

Novartis AG

Declared address

Novartis AG, 4056 Basel

2nd trading line buyback transactions

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Novartis AG

Novartis AG01.07.2022TAM6U00029

Disclosure summary

Novartis AG disclosed a holding in Novartis AG on the acquisition side, published by SIX Exchange Regulation on 01.07.2022, at 5.002% of voting rights. Notice category: Single shareholder.

Disclosed position

5.002%

Voting rights acquired

Voting rights acquired5.002%

Voting rights sold0.983%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

Novartis AG disclosed a holding in Novartis AG, published on 01.07.2022.

Publication date01.07.2022

Transaction date28.06.2022

Issuing companyNovartis AG

Beneficial ownerNovartis AG

Declared addressNovartis AG, 4056 Basel

CategorySingle shareholder

Voting rights acquired5.002%

Voting rights sold0.983%

Below threshold0%

ExchangeXSWX

Notification IDTAM6U00029

Commercial register

CHE-103.867.266

Registered

Zefix record

Conditions

2nd trading line buyback transactions

Source: SIX Exchange Regulation · Publication date: 01.07.2022

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open